Medicinal – Page 90

Molecular Docking, Synthesis, and Tyrosinase Inhibition Activity of Acetophenone Amide: Potential Inhibitor of Melanogenesis

mycolabadmin

Researchers developed new chemical compounds that can inhibit tyrosinase, an enzyme responsible for producing melanin (the pigment that colors skin). One compound, called 5c, proved exceptionally effective at blocking this enzyme—significantly more potent than existing skin-lightening agents. These acetophenone-based compounds could lead to improved cosmetic treatments for unwanted pigmentation like age spots and melasma, with better safety profiles than current options.

Approaches to Invasive Fungal Diseases in Paediatric Cancer Centres: An Analysis of Current Practices and Challenges in Germany, Austria and Switzerland

mycolabadmin

This study examined how 62 children’s cancer hospitals in Germany, Austria and Switzerland manage fungal infections in young cancer patients. Researchers found that hospitals use different methods to prevent and treat these serious infections, with some having special fungal infection experts and others not. The study revealed that larger hospitals tend to have better resources and expertise, while smaller hospitals face challenges like drug interactions and delays in getting test results.

Stage-Specific Lipidomes of Gastrodia elata Extracellular Vesicles Modulate Fungal Symbiosis

mycolabadmin

Researchers studied how a special orchid called Gastrodia elata communicates with its fungal partner Armillaria. They found that tiny fat-like packages called extracellular vesicles carry specific molecules that help the orchid and fungus work together. These special molecules, including compounds like 7,8-dehydroastaxanthin, are most abundant when the orchid is actively absorbing nutrients from the fungus.

John Perfect Shares Insights on Infectious Diseases, Antifungal Therapy, and Drug Resistance

mycolabadmin

This interview with Dr. John Perfect, a leading expert in fungal infections, discusses how antifungal treatments have evolved over his 48-year career. He explains that while fungal resistance is a concern, it’s less problematic than bacterial antibiotic resistance because fungi don’t spread resistance through plasmids. Dr. Perfect emphasizes the importance of newer, faster-acting antifungal drugs and combining drug therapy with immune system support to better treat serious fungal infections like cryptococcal meningitis and candidemia.

Exposure to Tebuconazole Drives Cross-Resistance to Clinical Triazoles in Aspergillus fumigatus

mycolabadmin

When farmers use antifungal pesticides called triazoles to protect crops, the fungi can develop resistance to these chemicals. This study found that when the fungus Aspergillus fumigatus is exposed to the agricultural triazole tebuconazole, it can become resistant not only to that pesticide but also to clinical triazole drugs used to treat human fungal infections. The resistant fungi maintain this resistance even when the pesticide is removed, suggesting that environmental pesticide use may threaten the effectiveness of medical antifungal treatments.

In vitro antifungal activity of plant extracts against fungal pathogens of onion (Allium cepa L.) and red pepper (Capsicum annum L.) in selected districts of Western Hararghe, Ethiopia

mycolabadmin

Onion and pepper farmers in Ethiopia lose significant crops to fungal diseases, and chemical fungicides are expensive and harmful. This study tested plant extracts from garlic, neem, and African wintersweet against disease-causing fungi. Acokanthera schimperi (African wintersweet) was most effective at stopping fungal growth, offering farmers an affordable, natural, and environmentally safe alternative to chemical fungicides.

Tailoring mRNA lipid nanoparticles for antifungal vaccines

mycolabadmin

Researchers are exploring mRNA vaccines, similar to those used for COVID-19, as a new approach to prevent fungal infections. These vaccines use fatty particles called lipid nanoparticles to deliver instructions to cells on how to make fungal proteins, triggering an immune response. The review discusses how to optimize these vaccines, what challenges need to be overcome, and why they might be especially useful for people with weakened immune systems who are most vulnerable to serious fungal infections.

Toward the consensus of definitions for the phenomena of antifungal tolerance and persistence in filamentous fungi

mycolabadmin

Scientists have proposed clear definitions and testing methods for two drug-resistance phenomena in fungi that cause infections. Unlike typical drug resistance, tolerance and persistence allow fungi to survive antifungal medications but in different ways: tolerance affects most spores while persistence affects only a small fraction. By standardizing how these phenomena are tested using fungal spores and measuring how quickly drugs kill them, researchers can better understand treatment failures and develop better therapies.

New wine in old skins: Scopoletin biosynthesis in cotton

mycolabadmin

Cotton farmers face significant crop losses from a soil-dwelling fungus called Verticillium dahliae. Scientists discovered that cotton plants can protect themselves by producing a compound called scopoletin, which damages and kills this fungus. By understanding how cotton activates the genes that make scopoletin, researchers may be able to genetically engineer more disease-resistant cotton varieties, providing farmers with a sustainable alternative to chemical pesticides.

Magnusiomyces capitatus bloodstream infection in a patient with acute monocytic leukemia: A rare case report

mycolabadmin

A 26-year-old patient with acute leukemia developed a serious fungal blood infection caused by Magnusiomyces capitatus, a rare organism found in environmental sources. The infection was confirmed using advanced molecular techniques and showed resistance to common antifungal drugs but responded to amphotericin B treatment. This case highlights how important it is for doctors to consider unusual fungi in severely immunocompromised patients and to use modern diagnostic methods for accurate identification and tailored treatment.

Research Topic: Medicinal